138 related articles for article (PubMed ID: 22673387)
1. Antineutrophil cytoplasm autoantibodies: usefulness in rheumatology.
Flores-Suárez LF
Reumatol Clin; 2012; 8(6):351-7. PubMed ID: 22673387
[TBL] [Abstract][Full Text] [Related]
2. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
Nakano H; Ozaki S
Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
[TBL] [Abstract][Full Text] [Related]
3. [Frequency and clinical associations of antineutrophil cytoplasmic antibodies. A regional experience].
Defendenti C; Spina MF; Grosso S; Longo M; Bollani S; Cereda A; Saibeni S; Guercilena G; Atzeni F; Sarzi-Puttini P
Recenti Prog Med; 2010 Jan; 101(1):16-26. PubMed ID: 20391682
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis.
Walsh M
Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):555-9. PubMed ID: 25144513
[TBL] [Abstract][Full Text] [Related]
5. [Approach and challenges in primary vasculitidies].
Zazueta Montiel B; Flores Suárez LF
Reumatol Clin; 2011 Dec; 7 Suppl 3():S1-6. PubMed ID: 22115870
[TBL] [Abstract][Full Text] [Related]
6. The future of ANCA-associated vasculitis.
Holle JU; Wieczorek S; Gross WL
Rheum Dis Clin North Am; 2010 Aug; 36(3):609-21. PubMed ID: 20688253
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in ANCA-associated vasculitis.
Wiik AS
Rheum Dis Clin North Am; 2010 Aug; 36(3):479-89. PubMed ID: 20688245
[TBL] [Abstract][Full Text] [Related]
8. An unusual presentation of C-ANCA vasculitis.
Gavrilovski M; Kakar P; Rendle J; Lawrence E; Kee K; Sathanathan R
QJM; 2012 Nov; 105(11):1105-7. PubMed ID: 21920993
[No Abstract] [Full Text] [Related]
9. Infective endocarditis by Bartonella quintana masquerading as antineutrophil cytoplasmic antibody-associated small vessel vasculitis.
Sugiyama H; Sahara M; Imai Y; Ono M; Okamoto K; Kikuchi K; Nagai R
Cardiology; 2009; 114(3):208-11. PubMed ID: 19602882
[TBL] [Abstract][Full Text] [Related]
10. Anti-neutrophil cytoplasmic antibody (ANCA) associated small-vessel vasculitis in a patient with diabetic nephropathy and autoimmune polyendocrinopathy syndrome (APS) Type 2: a case report.
Murray JS; Baines LA; Pearce SH; Ball S; Leech N; Wood KM; Kanagasundaram NS
Clin Nephrol; 2013 Sep; 80(3):223-6. PubMed ID: 22541677
[TBL] [Abstract][Full Text] [Related]
11. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of distinguishing and reporting different perinuclear ANCA (P-ANCA) immunofluorescence patterns: a prospective study.
Perel SB; Prain KM; Wilson RJ; Hogan PG; Gillis D; Wong RC
Am J Clin Pathol; 2013 Aug; 140(2):184-92. PubMed ID: 23897253
[TBL] [Abstract][Full Text] [Related]
13. [Primary systemic ANCA-associated vasculitis--recommendations concerning diagnosis and treatment].
Wiatr E; Gawryluk D
Pneumonol Alergol Pol; 2013; 81(5):479-91. PubMed ID: 23996888
[No Abstract] [Full Text] [Related]
14. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
[TBL] [Abstract][Full Text] [Related]
15. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Hasegawa M; Nishii C; Ohashi A; Tomita M; Nakai S; Murakami K; Nabeshima K; Fujita Y; Ishii J; Hiki Y; Sugiyama S
Nephron Clin Pract; 2009; 113(3):c222-33. PubMed ID: 19690440
[TBL] [Abstract][Full Text] [Related]
16. What to do when you suspect your patient suffers from pulmonary vasculitis?
Cohen Tervaert JW
Expert Opin Med Diagn; 2013 Jan; 7(1):1-4. PubMed ID: 23530839
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
[TBL] [Abstract][Full Text] [Related]
18. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.
Nagai M; Hirayama K; Ebihara I; Shimohata H; Kobayashi M; Koyama A
Nephron Clin Pract; 2011; 118(4):c339-45. PubMed ID: 21293157
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
